Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat

L Bjartmar, I M Johansson, J Marcusson, S B Ross, J R Seckl, T Olsson

Research output: Contribution to journalArticlepeer-review

Abstract

There is a latency period of several weeks before the onset of clinical effect of antidepressant drugs. The detailed mechanisms underlying drug-induced adaptive neuronal changes are not known. To elucidate the involvement of changes in gene expression of candidate transcription factors, we treated rats for 21 days with buspirone, fluoxetine, 8-OH-DPAT and moclobemide. In situ hybridization was used to study mRNAs encoding NGFI-A, NGFI-B and the glucocorticoid receptors, MR and GR. NGFI-A mRNA expression increased profoundly in the hippocampal formation and the cerebral cortex after all drug treatments, especially after moclobemide treatment (77-122% increase), with the exception of buspirone. MR mRNA expression was induced in hippocampal CA1/CA2 subregions (27-37%) by all antidepressants, while moclobemide and 8-OH-DPAT significantly increased GR gene expression mainly in the CA1 region (31-44%). NGFI-B mRNA was significantly decreased in the hippocampal CA3 subfield (23%) and restrosplenial granular cortex (38%) by moclobemide treatment. There ale selective effects of antidepressant drugs on specific transcription factors. These may be important fur adaptive neuronal and neuroendocrine changes after antidepressant treatment including HPA axis negative feedback regulation.

Original languageEnglish
Pages (from-to)712
Number of pages6
JournalPsychopharmacology
Volume151
Issue number1
DOIs
Publication statusPublished - Jul 2000

Fingerprint

Dive into the research topics of 'Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat'. Together they form a unique fingerprint.

Cite this